Form 4: McKesson EVP LeAnn Smith Reports Stock Transactions

Sentiment:

Insider Transaction Report


McKesson's EVP & Chief HR Officer, LeAnn Smith, reported the vesting of 508 Restricted Stock Units and the subsequent disposition of 129 shares for tax withholding.

Summary

  • LeAnn B. Smith, EVP & Chief HR Officer of McKesson Corp (MCK), reported changes in her beneficial ownership.
  • On February 10, 2026, 508 Restricted Stock Units (RSUs) vested.
  • These RSUs were part of a grant that vested in three equal tranches on February 10, 2024, February 10, 2025, and February 10, 2026.
  • Concurrently, 129 shares of common stock were disposed of at a price of $935.21 per share, likely for tax withholding purposes related to the RSU vesting.
  • Following these transactions, Smith directly owns 3,179 shares of McKesson common stock.
  • The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and expected executive compensation event, reflecting the successful vesting of long-term incentives. The disposition of shares for tax purposes is standard practice and does not indicate a negative sentiment towards the company.

Positives

  • Vesting of 508 Restricted Stock Units indicates a successful long-term incentive compensation payout for the executive.
  • The executive continues to hold a significant number of shares (3,179), demonstrating ongoing alignment with shareholder interests.

Negatives

  • The disposition of 129 shares, while likely for tax purposes, represents a reduction in direct ownership.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and subsequent tax-related sales, are common across all industries for executives receiving equity compensation. These transactions typically reflect pre-scheduled compensation events rather than discretionary trading based on new material information.

Comparison to Industry Standards

  • This Form 4 details standard executive compensation practices involving Restricted Stock Units (RSUs) and subsequent share dispositions for tax purposes, which is a common mechanism for long-term incentive plans across S&P 500 companies.
  • Similar RSU vesting and tax-related sales are frequently observed in filings from executives at peer companies like Cardinal Health (CAH) or AmerisourceBergen (ABC), which also operate in the pharmaceutical distribution sector.
  • The disposition price of $935.21 per share reflects the market value at the time of the transaction, consistent with how such tax obligations are typically settled.

Stakeholder Impact

  • Shareholders: The vesting of RSUs aligns executive interests with long-term shareholder value creation. The tax-related sale is a minor, routine event.
  • Employees: This filing pertains to executive compensation and does not directly impact the broader employee base.

Key Dates

DateDescription
02/10/2024First tranche of RSUs vested.
02/10/2025Second tranche of RSUs vested.
02/10/2026Third tranche of RSUs vested, leading to the reported transactions.
02/12/2026Date the Form 4 was signed.

Recommendation

hold

This Form 4 filing details a routine, pre-scheduled insider transaction involving the vesting of Restricted Stock Units and a subsequent sale for tax purposes. Such transactions are common for executives and do not typically signal a change in the company's fundamental outlook or the executive's confidence. Given the nature of the transaction, it provides no new material information that would warrant a change in investment recommendation; therefore, a "hold" recommendation is appropriate, maintaining existing positions based on broader company fundamentals.

Keywords

McKesson Corp, MCK, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, LeAnn Smith, Tax Withholding, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.